To describe the association between opioid administration in the newborn period and neurologic abnormalities
Opiates are widely used in neonatal intensive care units for routine sedation/analgesia of critically ill neonates receiving mechanical ventilation, as well as for postoperative pain control.
1 Seizure activity as a complication of opioid administration has been reported in the literature in laboratory animals, 2 adult humans 3-5 and neonates. 6 Electrical seizure activity induced by opiates has been well documented with electroencephalogram (EEG) recording in animals. 2 The correlation between abnormal movements and electrical seizures is less consistent in adult humans receiving opiates 5, [7] [8] [9] and is lacking in the neonatal patient. The objective of our study is to report on two infants with abnormal electroencephalographic findings while receiving opioids. One infant presented with clinical and electroencephalographic seizure activity. The second infant had a grossly abnormal EEG pattern.
CASE 1
Baby girl M was born at 39 weeks' gestation by elective cesarean section to a 34-year-old mother. The birth weight was 3975 gm, the cord arterial pH was 7.34, and the Apgar scores were 9 and 9 at 1 and 5 minutes, respectively. The baby was admitted to the normal newborn nursery for routine care. She was transferred to the neonatal intensive care unit (NICU) at 24 hours of age due to abdominal distention and bilious vomiting. Radiologic studies revealed a small bowel obstruction and she was operated at 35 hours of age for congenital ileal atresia. She received a cumulative dose of 20 g (5 g/kg) of fentanyl for anesthesia and 1 mg (0.25 mg/kg) of morphine in the operating suite for pain control (increased heart rate and increased blood pressure during operation). There were no complications during the surgery. Fifteen minutes postoperatively she was noted to have abnormal movements (fasciculation of the tongue and lips). A continuous infusion of fentanyl was started at a rate of 5g/kg per hour beginning 30 minutes postsurgery, because it was felt that analgesia was inadequate. The infusion rate was increased to 10 g/kg per hour at 2 hours postoperatively without cessation of the abnormal movements. Two hours later, seizure-like abnormal eye movements and stiffening of the upper limbs were noted. She was given phenobarbital, 20 mg/ kg, intravenously, followed by two further doses of phenobarbital, 10 mg/kg each, at 4 and 8 hours after surgery. The abnormal movements persisted despite the anticonvulsant therapy. An EEG was performed at about 9 hours postsurgery, which showed a multifocal epileptiform pattern with incomplete generalized suppression throughout the recording. A single trial dose of naloxone, 0.1 mg/kg, was given intravenously because the baby had intermittent seizurelike muscle activity despite phenobarbital therapy. Abnormal movements ceased immediately, and the baby "woke up" and started to cry. The fentanyl infusion was discontinued and no further abnormal Original Article
movements were noted. A repeat EEG 4 days later showed substantially less epileptiform activity without background suppression pattern. All biochemical investigations together with cranial ultrasound were normal. The baby was discharged on day 10 in excellent condition, and she was developing normally at the last follow-up visit at 3 years of age.
CASE 2
Baby boy L was born at 27 weeks' gestation to a 31-year-old primigravida mother by spontaneous vaginal delivery. The Apgar scores were 9 and 10 at 1 and 5 minutes, respectively, and the birth weight was 1100 gm The infant was transferred to our center at 14 days of age, due to increasing respiratory failure. At the time of transfer he was paralyzed with muscle relaxants and was receiving a morphine infusion at 10 g/kg per hour. Because of the muscle paralysis, an EEG was performed on admission to exclude seizure, and because there was a history of abnormal movements 4 days before transfer to our service that were treated with phenobarbital. The EEG tracing showed a burst-suppression pattern with epileptiform activity (Figure  1 ). At the time of the EEG he was receiving the following medications: morphine (10 g/kg per hour), dopamine (2 g/kg per minute), vecuronium (0.1 mg/kg per hour), and dexamethasone (0.5 mg/kg per day). Biochemical screening, including serum electrolytes, calcium, magnesium, and blood sugar, were within normal range. A cranial ultrasound examination showed a resolving small subependymal hemorrhage on the right side. It was suspected that the abnormal EEG pattern might be related to the morphine infusion, so naloxone (0.1 mg/kg intravenously) was given under continuous EEG monitoring. The EEG recording became continuous with substantially reduced epileptiform activity ( Figure  2 ). The patient was discharged at 46 days of age in good condition. His development was normal at the last follow-up visit at 2.5 years of age.
DISCUSSION
Despite relatively good documentation of seizure activity associated with opiate infusions in experimental animals and adult human subjects, to our knowledge such a documentation is lacking in the neonatal period. Koren et al. 6 reported 12 neonates who received a morphine infusion. Two of these patients developed generalized seizure activity associated with the morphine administration at high continuous infusion rates. Seizures stopped a few hours after discontinuation of the drug, and the investigations failed to reveal other reasons for convulsion. 6 A question remains as to the exact etiology of seizure activity in these complex patients receiving concomitant infusion of opioids. The first of our patients was a healthy term infant who underwent elective correction of bowel obstruction in the operating room and convulsed shortly after returning to the NICU. The infant was not asphyxiated at birth, the surgery was uneventful, she had no intracranial pathology on ultrasound examination, and biochemical investigations were normal. Other than the opioid infusion, there was no recognizable cause for convulsion. This etiology was strengthened with the complete cessation of seizure activity after the administration of naloxone and interruption of the fentanyl infusion. It is not clear why, despite the short half-life of naloxone in comparison to opiates, only a single dose was required to reverse the seizure activity observed in this patient. This could be a result of the shorter duration of action of a continuous infusion of fentanyl, the fact that the infusion was immediately stopped, or some other possibility.
The second case was a premature infant with severe lung disease who was referred to our unit from another facility. The abnormal EEG findings during the administration of morphine and the improvement on the tracing after administration of naloxone supports the hypothesis that the observed electrical seizure was secondary to the morphine. Similar to our first patient, a workup for seizures and clinical follow-up failed to reveal other reasons for the abnormalities observed on the EEG. In neither case was there a family history of seizures or maternal history of drug abuse. Further seizure workup, including computerized tomography scan, magnetic resonance imaging, or inborn error of metabolism screening, was not done in our cases because the patients were well after discontinuation of opioid infusion. In the absence of other explanations for the seizure activity in these patients we describe, it is reasonable to attribute the clinical and EEG abnormalities observed to the infusion of opiates, despite the limitations of our study.
The mechanism by which opiates induce seizures is not well known. The suggested hypotheses are that opioids exert their epileptogenic effects by disinhibition of hippocampal pyramidal neurons 10 or by the enhancement of excitatory neurotransmission. 11 Despite the widespread use of opiates for pain control, convulsions are not usually observed at therapeutic dosages; however, seizure may be triggered at doses only moderately higher than those required for analgesia, especially in the susceptible pediatric patient. 12 Naloxone is a pure opiate antagonist used in the treatment of narcotic overdose associated with clinical effects such as respiratory depression, coma, and convulsions. 12 A test dose of naloxone could be used as a diagnostic aid in the infant who shows suspicious motor activity while receiving a narcotic infusion and other causes for the seizures have been excluded.
We suggest that critically ill neonates receiving opiates should be carefully monitored for seizure activity. This is particularly important for those patients who are receiving concomitant muscle relaxants, because motor seizure activity will not be observed in paralyzed infants. Figure 2 . After naloxone treatment. The figure shows a continuous EEG pattern, without periods of suppression, a mixture of symmetrical rhythmic waves in the delta and theta frequency bands, and intermittent complexes with epileptiform discharges (here roughly periodic every 4 or 5 seconds) mainly in the right posterior head. The epileptiform discharges were more spatially confined, less abundant, and of lower voltage than before the naloxone was administered.
